“When we own portions of outstanding businesses with outstanding managements, our favorite holding period is forever.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a two-decade holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Nektar Therapeutics (NASD: NKTR)? Today, we examine the outcome of a two-decade investment into the stock back in 1999.
| Start date: | 07/19/1999 |
|
|||
| End date: | 07/18/2019 | ||||
| Start price/share: | $24.12 | ||||
| End price/share: | $32.07 | ||||
| Starting shares: | 414.51 | ||||
| Ending shares: | 414.51 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | 32.93% | ||||
| Average annual return: | 1.43% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $13,286.06 | ||||
As shown above, the two-decade investment result worked out as follows, with an annualized rate of return of 1.43%. This would have turned a $10K investment made 20 years ago into $13,286.06 today (as of 07/18/2019). On a total return basis, that’s a result of 32.93% (something to think about: how might NKTR shares perform over the next 20 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
Here’s one more great investment quote before you go:
“The most important thing about an investment philosophy is that you have one.” — David Booth
